University of California, Los Angeles

Award Value
Disease Team Planning: Stanley Carmichael Development of a Stem Cell Therapy to Promote Functional Recovery in Stroke $42,748
Early Translational from Disease Team Conversion: Irvin Chen HPSC based therapy for HIV disease using RNAi to CCR5. $1,505,000
Tools and Technologies I: Michael Phelps Novel Tools and Technologies for Translational PET Imaging of Cell-based Therapies $914,039
Tools and Technologies I: Hsian-Rong Tseng Microfluidic Platform for Screening Chemically Defined Conditions that Facilitate Clonal Expansion of Human Pluripotent Stem Cells $914,096
Disease Team Therapy Development III: Dennis Slamon A Phase I dose escalation and expansion clinical trial in patients with advanced solid tumors $6,924,317
Basic Biology V: Thomas Otis In vitro modeling of human motor neuron disease $1,148,758
Basic Biology V: Samantha Butler Assessing the mechanism by which the Bone Morphogenetic Proteins direct stem cell fate $545,962
Disease Team Planning: Irvin Chen Stem Cell Therapy for AIDS- Disease Team Planning $51,490
Basic Biology V: Lili Yang Differentiation of Human Hematopoietic Stem Cells into iNKT Cells $614,400
Total:
$12,660,810.00

Pages

Icon for xls export